A placebo-controlled, double-blind, randomized, parallel-group study of the efficacy and safety of dapoxetine in the treatment of men with premature ejaculation
Phase of Trial: Phase III
Latest Information Update: 30 Mar 2010
At a glance
- Drugs Dapoxetine (Primary)
- Indications Premature ejaculation
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Janssen Research & Development
- 08 Apr 2009 Actual end date (Jun 2006) added as reported by ClinicalTrials.gov.
- 11 Oct 2007 Status changed from in progress to completed.
- 04 Dec 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History